Jan 07, 2025 1-7PM | marcello 4404, Venetian | Las Vegas @ces
The Super Bowl of NeuroTech at CES
Brain-Computer Interfaces | Wearable Neuro-Devices | Cognitive Enhancement Tools
#NeuroTech @ CES 2025
Unlock the future of healthcare
Discover groundbreaking innovations set to transform healthcare and human-computer interaction. Join industry leaders as they explore brain-computer interfaces, wearable neuro-devices, and cognitive enhancement tools poised to revolutionize neurological treatments. Be part of this exclusive CES conference and gain insights into technologies driving new revenue streams and reshaping industries. Don't miss your chance to connect with healthtech executives, investors, and pioneers at the forefront of neurotech.
Our Speakers
Simon Bachmann
CEO | IDUN Technologies
Simon Bachmann is a first-time founder with the vision to enable the Internet of Humans. I am interested in wearable technology which enables humans to more intuitively engage with each other and the digital world. As a co-founder and chief executive officer of IDUN Technologies Simon is excited by building world-class teams, building win-win partnerships with customers and research institutions to make the next-generation of wearables a reality.
Ariel Garten
Co-Founder | Muse
As a neuroscientist and former psychotherapist, Ariel Garten witnessed firsthand the struggles many face with mental health and the search for effective, accessible solutions. Inspired to make a real difference, she channeled her expertise into co-founding Muse, a healthtech startup aimed at revolutionizing brain health through technology.
Muse, the brain-sensing EEG headband, has helped over half a million users globally improve their meditation, reduce stress, and enhance sleep quality. By providing real-time biofeedback on brain activity, heart rate, and body movements, Muse supports personal brain training and offers valuable insights for both consumers and neuroscience researchers. Trusted by medical providers and featured in over 200 third-party studies, Muse is on path to unlocking the brain and revolutionizing health.
Ariel and Muse have been featured in thousands of articles including major media outlets such as CNN (3x), Forbes, Fortune, Popular Science, NTY, WSJ, GQ, Men’s Health, O Magazine, Wired, and more.
Driven by a deep passion for understanding the human mind, Ariel is committed to empowering individuals to enhance their mental capacities. Through Muse, she provides innovative tools and insights that motivate people to actively engage in their wellness journeys, inspiring them to achieve their full potential. Ariel is a sought after speaker on the global stage.
Jason McKeown
CEO | Neurovalens
Dr. Jason McKeown is CEO of Neurovalens, a UK-based medical device company that has recently received two FDA 510(k) approvals for the Modius range of devices that are prescribed treatments used in the comfort of the patients home. Both Modius Sleep (indicated as treatment for chronic insomnia) and Modius Stress (indicated as a treatment for generalized anxiety disorder) are already being prescribed by clinicians across the US.
Dr McKeown is a UK-trained medical doctor with a PhD in Non-invasive Neurostimulation. He currently holds academic positions at Stanford University (Department of Neurosurgery), UC San Diego (Department of Psychiatry), and Ulster University (School of Medicine).
Through his work in the field of neuroscience and interest in advanced technology, he believes there is a better way to treat diseases affecting the lives of people worldwide. His dedication to advancing medical technology, combined with his deep understanding of both mental and metabolic health has positioned him as a trailblazer in the field.
Jessica Randazza-Pade
Vice President, Marketing & Communications | Neurable
Jessica Randazza-Pade is an accomplished global digital marketer and business leader, currently serving as the Vice President of Marketing and Communications at Neurable, a brain-computer interface company. With a proven track record of driving explosive growth, she has worked with Fortune 100 companies and startups alike.
As a serial entrepreneur, Jessica has successfully built and sold companies, and has held leadership roles at renowned organizations such as IDEO, Danone, and DigitasLBi. Recognized as a Brand Innovators 40 under 40 and an Elle Magazine 30 under 30, she is a respected voice in the global startup community.
Jessica is passionate about leveraging data-driven, real-time marketing strategies to achieve business objectives. She is a skilled storyteller and consultant, helping organizations to innovate and transform through human-centered design and strategic marketing.
Bjoern Wolterman
Founder & CEO | Katalyst
Bjoern Woltermann is the Founder & CEO of Katalyst, which utilizes full-body Electro Muscle Stimulation (EMS) technology to make working out easier, faster, safer and more effective than ever before. A startup and tech veteran with a master's degree in international economics, Bjoern became acutely aware of the challenges with traditional fitness when he took 150 flights per year while suffering from chronic back pain. Bjoern’s physician introduced him to EMS training and, after training once per week for six weeks, he was pain-free and in noticeably better shape. This began a ten-year journey to introduce full-body EMS to the US market and help all people live longer, healthier and happier lives.
Prior to founding Katalyst, Bjoern led product management teams at ImmobilienScout24 (the Zillow of Europe) and, following the acquisition by Deutsche Telekom, served as VP of Emerging Technologies for the telco conglomerate, leading teams in 15 countries.
Bjoern is passionate about helping people, learning and problem solving, leading to 11 patents to date. Now based in Las Vegas, NV, he is a devoted husband and uncle who loves to explore the world off the beaten paths, enjoy great food, and pursue a healthy lifestyle.
Tam Vu
Distinguished Professor | Dartmouth
Dr. Tam Vu is a Distinguished Professor at Dartmouth College and the Founder/CEO of Earable Neuroscience. He coined the term “Earable Systems” and holds 35+ patents. Tam has led Earable's FRENZ Brainband to raise from Founders Fund and Samsung Ventures and 3x CES Innovation Awards (2023-2025). He advances AI wearables for digital health and longevity science and has been honored with the Alfred P. Sloan Fellowship, NSF CAREER Award, Google Research Awards, and 12 Best Paper Awards.
Kimi Doan
Chief Innovation Officer | Earable.AI
Kimi Doan is the Chief Innovation Officer at Earable Vietnam - a subsidiary of Earable Inc., an award-winning deep tech company pioneering sleep technology wearables. She leads investor relations, strategic product innovation, and partnerships across global healthcare industries.
Kimi is a seasoned Tech Evangelist and Business Connector with a strong background in computer science and a deep passion for neuroscience. With over 15 years of experience in executive roles in global marketing communications and business development for emerging technology companies, she is now a dedicated sleep advocate, committed to enhancing health, wellness, and unlocking human potential and longevity.
Before joining Earable Vietnam, Kimi was the Founder of YellowBlocks, Vietnam’s first emerging tech consulting firm with a network of over 120 tech organizations across 40 countries and strong partnerships with the governments of Vietnam, Australia, Singapore, and Austria. She also served as the first Global CMO for VinFast (NASDAQ: VFS) from 2020-2022, where she laid the foundation for the brand’s global launch.
Kimi holds a BSc in Computer Science and Telecommunications with merit from Helsinki University of Technology and an MBA with first-class honors from the University of Gloucestershire, UK.
Maynard Okereke
Founder | Hip Hop Science
Ryan Field
CEO & CTO | Kernel
Ryan Field is the CEO of Kernel, a neurotechnology company dedicated to building actionable insights from high-quality brain data. He previously led the Kernel Flow team and served as CTO, overseeing the concept, design, and development of the category-defining Kernel Flow brain imaging system.
Ryan is an inventor with more than 20 granted US patents and a published researcher with over a decade of experience building complex sensing systems. He holds a PhD from Columbia University in Electrical Engineering and previously led teams at Intel and Quanergy.
Tan Le
Founder & CEO | Emotiv
Tan Le (BCom (Hons), LLB (Hons)) is an inventor, entrepreneur, and thought leader in neurotechnology. As the founder and CEO of EMOTIV, she has
spearheaded innovations in portable EEG devices, transforming the understanding of brain performance and cognitive health.
Recognized as a Young Global Leader by the World Economic Forum since 2009, Tan has served on the WEF’s Board of Stewards on Neurotechnology and
contributed to shaping the future of information and entertainment. She received the 2018 Industrial Research Institute Achievement Award for her groundbreaking work in advancing industry and society.
Tan’s entrepreneurial journey began with SASme International, where she led a successful merger. Her accolades include Forbes’ "50 Names You Need to Know"
and a National Geographic Emerging Explorer. Tan also serves on the Group Board of QBE Insurance, underscoring her leadership across diverse industries.
Nickolai Vysokov
CEO | BrainPatch
Nickolai is a neuroscientist with a PhD from Imperial College London, a prolific speaker on a range of neuroscience topics and a co-founder and CEO of BrainPatch.AI. BrainPatch was founded with a vision to change the world through allowing everyone to tap into the hidden potential of our brains using two-way brain-computer interfaces. Together with his team they developed effective stimulation protocols that mimic the sensations of meditation and deliver similar benefits for mental well-being, specifically for reducing stress and burnout.
Sandy Carter
COO, Author, Founder | Unstoppable / Women of AI and Web3
Sandy Carter has had a distinguished career, holding leadership positions as Chief Operations Officer, Chief Marketing Officer, Chief Sales Officer, Channel Chief, and Chief Product Officer, working for two Fortune 100 companies – AWS and IBM. Her background is unique, as very few executives have experience working in such diverse C-level roles. At IBM, she was a pioneer in AI innovation, contributing to the development of the Watson ecosystem, including Cloud, AI, and IoT, and playing a pivotal role in introducing the industry's first business model for the AI ecosystem.
Sandy's passion for collaborating with partners and delivering value to customers was further demonstrated during her tenure as a top executive at AWS, where she worked closely with C-level customers and partners to address their Cloud, AI, and tech challenges. She credits her teams for their success, acknowledging that while she provides the direction and strategy, they drive the innovations and breakthroughs in AI and emerging technologies. She has also held Board of Director positions, currently serving on the Altair Board, and has been recognized with numerous awards, including AI Executive Champion of the Year, Business Transformational Leader of the Year, and CNN's Top 10 Women in Tech.
Connor Glass
Founder & CEO | Phantom Neuro
Connor Glass is the Founder & CEO of Phantom Neuro which enables life-like control of robotic prosthetic limbs and exoskeletons for individuals with limb difference. Glass received his medical degree from the University of Oklahoma College of Medicine followed by a research fellowship in Plastic & Reconstructive Surgery at Johns Hopkins University School of Medicine, where he studied surgical interventions for neuromuscular injury, and advanced prosthesis control. Ultimately, Glass and his collaborators invented a minimally invasive neural interface that could enable the merging of humans and robots so that individuals with limb loss can control robotic limbs the same as natural limbs. Glass has multiple publications on nerve injury and neuromuscular reconstructive surgery, is a TEDx speaker, and a recognized leader in human-machine interfacing. His work has been featured in outlets such as the WIRED, The Wall Street Journal, Axios, and STAT.
Susan Sly
Founder & CEO | ThePause.ai
Susan Sly has been voted as one of the top female entrepreneurs in Artificial Intelligence in 2023. She is the CEO and founder of ThePause.AI, former Co-CEO and Co-Founder of an AI-driven retail and healthcare computer vision company, a tech investor, and podcast host of the highly acclaimed show - Raw and Real Entrepreneurship. She has appeared on CNN, CNBC, Fox, Lifetime Television, The CBN, The Morning Show in Australia and has been quoted in MarketWatch, Yahoo Finance, Forbes, and more. She is a graduate of MIT Sloan.
As a highly acclaimed keynote speaker, Susan has spoken for MIT, NVIDIA, HPE, Intel, Lenovo, and shared the stage with Tony Robbins, Jack Canfield, Robert Kiosaki, and more. Susan has served as a distinguished guest speaker at prominent events such as the National Restaurant Association, MIT Sloan, Executive Next Practices Institute, Forbes Roundtable, Corenet Global, The Big Data and AI Summit, HPE Discover, The Edge AI Summit, and various others.
In 2022, Susan was honored to receive the Rosalind Franklin Society Award in Science and a nomination for the Rising Star in AI from Venture Beat.
Dale DiMassi
Creative Specialist | PSYONIC
Alexandra Zimmerman
CEO & Co-Founder | BrainSpec
Alexandra Zimmerman is the CEO of BrainSpec, a pioneering precision neuroimaging startup founded at Mass General Brigham. She holds degrees in Mechanical Engineering from Tufts, Biomedical Engineering from Brown, and an MBA from Harvard Business School, where she was honored with the R.F. Jasse Distinguished Award in Entrepreneurship.
Her experience as a Blavatnik Fellow in Life Science Entrepreneurship at Harvard University was instrumental in the company’s success, bridging the gap
between cutting-edge scientific research and clinical translation. Under Alex’s leadership, BrainSpec has achieved significant milestones, including FDA clearance for its AI-powered virtual biopsy technology, the development of a first-of-its-kind brain chemistry database, and Breakthrough Device Designation
for detecting 2-hydroxyglutarate in gliomas. This breakthrough technology holds great potential for advancing the understanding and treatment of neurological disorders. Alex’s work exemplifies the intersection of innovation, science, and real-world impact.
Aadeel Akhtar
Founder & CEO | PSYONIC
Dr. Aadeel Akhtar, CEO of PSYONIC, founded the company to create advanced, affordable prostheses after meeting a young girl with a limb difference in Pakistan. PSYONIC's bionic Ability Hand is the fastest on the market, impact-resistant, and the first to provide a sense of touch. Dr. Akhtar earned a Ph.D. in Neuroscience and an M.S. in Electrical & Computer Engineering from the University of Illinois, along with a B.S. in Biology and an M.S. in Computer Science from Loyola University Chicago. In 2021, he was named as one of MIT Technology Review’s top 35 Innovators Under 35 and America’s Top 50 Disruptors in Newsweek. In 2024, he secured a 3-shark deal on Shark Tank.
Jen French
Executive Director and Founder | Neurotech Network
Jennifer French is the Founder and Executive Director of Neurotech Network, a nonprofit organization that focuses on education and advocacy of neurotechnologies. French has helped launch successful divisions is such organizations as Bombardier Capital and Connection, as well as several nonprofit organizations and community/patient engagement programs. She serves on several Boards including the IEEE Neuroethics Initiative, Institute of Neuroethics, OpenMinds, BRAIN
Initiative MCWG & NEWG, and the American Brain Coalition. She is also a faculty member for the NeuroTech Course. Together with Drs. Hochberg & Lennerz, Jennifer recently launched the Implantable BCI Collaborative Community (iBCI-CC), a multi-stakeholder forum dedicated to
advancing regulatory science in iBCIs.
As a result of a snowboarding accident, Jennifer French lives with tetraplegia due to a spinal cord injury. She is an early user of an experimental implanted neural prosthesis for paralysis and is the Past-President and Founding member of the North American SCI Consortium. French is the current Chair of the CDMRP Spinal Cord Injury Research Program programmatic committee. She is the author of On My Feet Again (Neurotech Press, 2013) and is co-author of
Bionic Pioneers (Neurotech Press, 2014).
Jen is also an avid sailor. She is a silver medalist from the 2012 Paralympic Games and is the 2012 Rolex Yachtswoman of the Year; the first woman with a disability to receive this distinction. She is the 2024 recipient of the Craig H. Neilsen Foundation Visionary Prize and the recipient of the Brooke Ellison Community Visionary Award.
Geoff Klaas
Founder & CEO | Sense Diagnostics
Respected senior executive in business and community leadership. With over 30 years of building commercial organizations, from startups to global enterprises; Geoff has a deep healthcare and neuro innovation background.
Jacob Robinson
CEO & Co-Founder | Motif Neurotech
Jacob Robinson is the co-founder and CEO of Motif Neurotech, a company developing neurotechnology to treat and track mental illness, and a professor of Electrical and Computer Engineering at Rice Univeristy. He holds a Ph.D. in Applied Physics from Cornell and completed his postdoc at Harvard.
Prior to founding Motif, Jacob led a research group at Rice University for 12 years, publishing over 60 peer-reviewed papers in top journals like Nature and Science. His lab's innovations in brain-computer interfaces (BCI) and bioelectronics attracted over $40 million in federal and private funding. Although now leading Motif full-time, Jacob remains a professor at Rice. His work has earned him the Charles Duncan Award, the DARPA Young Faculty Award, and the Materials Today Rising Star Award.
Jacob previously co-chaired the IEEE Brain Initiative and is a senior member of IEEE and IEEE EMBS. Motif Neurotech aims to pioneer psychiatric BCI technologies under his leadership.
Usha Jagannathan
Director, AI Products | IEEE SA
Dr. Usha Jagannathan, a trailblazer in Responsible AI, empowers organizations to build trustworthy, impactful AI solutions. With over 25 years of experience, she is a seasoned technologist and has previously led the AI innovation team at McKinsey. Currently, she leads AI Products at IEEE Standards and champions diversity in tech. A passionate educator mentoring part-time at Arizona State University, she empowers future tech leaders and has secured jobs for over 1,000 students, particularly young women in STEM.
She was honored as the 'AI and Data Science Leader of the Year for 2024' by the WomenTech Network. Her other recent recognitions include 'AI Evangelist' from AI2030, 'Top 1% Mentor in North America' from Topmate, 'Responsible AI Leader of the Year' from Women in AI, and she was featured in CIOTimes magazine as one of the 'Most Iconic Women Leaders Creating Waves in the Modern AI Industry.'
Tara Scudder
Anosmia Ambassador | Osmocosm
My background is in the world of entertainment and advertising technology and I currently serve as an Senior Ad Operations Specialist with the industry-leader, Tubi. However, being an advocate for others suffering with a form of smell loss and bridging the gap with tech pioneers is my passion project.
Most people have never heard of the word 'anosmia' or even know that the ability to not have a sense of smell is a part of some people's reality. As a congenital anosmic (born without sense of smell) I'm set out to change that and bring awareness to the issue. I've served on the Board of Directors for a non-profit called 'Osmocosm' which brought together innovators worldwide in the area of olfaction technology for a conference held at MIT.
I'm always open for conversations involving the subjects of smell and technology. Free to reach out to me at tara@tarascudder.com.
Executive Producer - Pete Erickson
CEO | Modev
Pete is the founder and CEO of Modev and the creator of a diverse series of events including VOICE & AI, GovAI Summit, CodeForward, BrandsGPT, and GNRT.AI.
Event Schedule
-
1-1:40PM - From Therapy to Transformation: Clinical Frontiers of Brain-Computer Interfaces
Explore the cutting-edge of clinical brain-computer interface technology, from implants transforming neurorehabilitation to breakthroughs in restoring lost sensory and motor functions, and the ethical landscape shaping this revolutionary field. -
2-2:40PM - Everyday Neurotech: Brain-Computer Interfaces for All
Discover how wearable brain-computer interfaces are unlocking new possibilities for mental wellness, productivity, and creativity, bringing neurotechnology out of the lab and into daily life. -
3-3:40PM - NeuroTech in Healthcare: Revolutionizing Diagnosis and Treatment
Discover how NeuroTech is transforming healthcare with advanced neuroimaging, AI-driven diagnostics, and personalized treatments for neurological disorders. -
4-4:40PM - The Future of NeuroTech: Exploring Tomorrow’s Innovations
Explore groundbreaking innovations and the evolving impact of NeuroTech on society, health, and human potential, as experts chart the path ahead. -
5-7:00PM - Evening Reception
Immediately following the day's program, stay with us for an evening cocktail reception and continue the conversation! RSVP REQUESTED. MUST BE REGISTERED FOR CES.
Leave your mark
Interest in speaking or sponsoring?
@ CES 2025
Ready to Experience the Next Level of NeuroTech?
Step one: Register below
Sign up for CES through the official CES website to secure your spot at this premier event.
Step Two: Select NeuroTech
During the registration process, be sure to choose the "NeuroTech @ CES" conference track to access specialized sessions and insights tailored to neurotechnology advancements.